A Study of Vismodegib (GDC-0449, Hedgehog Pathway Inhibitor) As Maintenance Therapy in Patients With Ovarian Cancer in a Second or Third Complete Remission
Clinical trial NCT00739661 · COMPLETED
Trial details
- NCT number
- NCT00739661
- Sponsor
- Genentech, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-12-01
- Primary completion
- 2010-11-01
- Enrollment
- 104
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.